Medicare drug coverage
Revlimid: 2027 Medicare Part D coverage
The CMS 2027 formulary file (each plan's list of covered drugs) has no row matching the RxNorm products for Revlimid across 5,495 Part D plans. RxNorm is the National Library of Medicine's list of drug names and products. In 2026, 228 of 5,518 plans listed it. A missing row can be a product the file codes another way, so this is a lookup result, not a coverage decision. Plan counts include both Medicare Advantage plans with drug coverage (5,172 MA-PD) and stand-alone drug plans (323 PDP).
License: a US government work, in the public domain (Public Domain Mark 1.0).
Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.
For pharmacies and agencies: check a whole drug list against 2027 formularies.
Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.
2027 compared with 2026
Revlimid is number 10 by total Medicare Part D spending in 2024 ($4.2 billion). Counts use 7 RxNorm products for this name.
| Measure | 2026 | 2027 | Change |
|---|---|---|---|
| Part D plans in the file | 5,518 | 5,495 | -23 |
| Plans that list it | 228 (4%) | 0 (0%) | -4 points |
| Prior authorization (of plans that list it) | 228 (100%) | 0 | no plans list it in 2027 |
| Step therapy (of plans that list it) | 0 (0%) | 0 | no plans list it in 2027 |
| Quantity limit (of plans that list it) | 222 (97%) | 0 | no plans list it in 2027 |
| Any of the three (of plans that list it) | 228 (100%) | 0 | no plans list it in 2027 |
| Not listed or restricted (of all plans) | 5,518 (100%) | 5,495 (100%) | no change |
Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page
Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page
Other Lenalidomide products
Near it by Part D spending
About this data
A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.
A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.
Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page
Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page
Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page